Biomea Fusion, Inc. SEC filings BMEA
Biomea Fusion, Inc. has 290 filings in SEC EDGAR's recent list, going back to Jan 15, 2021. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 14, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Other events
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K | Current report | Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 7, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 6, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 20, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice, Officer or director change, Regulation FD disclosure
|
Mar 27, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 28, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Other events
|
Jan 15, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 31, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Other events
|
Sep 27, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Other events
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Other events
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Other events
|
Mar 7, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Other events
|
Jan 10, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Other events
|
Jul 25, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Other events
|
May 2, 2023 | May 1, 2023 |
| 8-K |
Current report
Results of operations
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 3, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Other events
|
Jan 12, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 16, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Other events
|
Dec 13, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Material agreement
|
Nov 25, 2022 | Nov 25, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Other events
|
Nov 1, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Other events
|
Oct 18, 2022 | Oct 14, 2022 |
| 8-K |
Current report
Other events
|
Sep 23, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Other events
|
Sep 22, 2022 | Sep 20, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 9, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Other events
|
Aug 29, 2022 | Aug 26, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Other events
|
Jun 6, 2022 | Jun 4, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2022 | Apr 19, 2022 |
| 8-K |
Current report
Other events
|
Apr 8, 2022 | Apr 8, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2021 | Nov 3, 2021 |
| 8-K |
Current report
Other events
|
Sep 17, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 19, 2021 | Jul 19, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 12, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Results of operations
|
May 27, 2021 | May 27, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Apr 20, 2021 | Apr 20, 2021 |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMEA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Carlos, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840439
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.